PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Breast Cancer Research1 citationsOpen Access

Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema

View Full Paper
MAMelissa B. AldrichMMMeghan E McWainSSSimona F. Shaitelman

Key Points

  • This research investigates the role of lymphatic pump failure in breast cancer-related lymphedema development.
  • Prospective observational cohort study on breast cancer patients
  • Lymphatic imaging used to visualize arm lymphatics
  • Pumping frequencies measured at five timepoints after treatment
  • Statistical analyses including repeated measures mixed-effects and Wilcoxon tests
  • Lymphatic pumping failure observed before clinical lymphedema diagnosis
  • Failure measured at multiple timepoints post-treatment
  • The hypothesis that lymphatic dysfunction is the initial step in lymphedema development is supported

Abstract

Breast cancer patients who undergo regional nodal irradiation therapy (RNI) following neoadjuvant chemotherapy and mastectomy or lumpectomy with axillary lymph node dissection (ALND) frequently encounter breast cancer-related lymphedema (BCRL). Early detection and treatment can significantly improve outcomes. Previously, near-infrared fluorescence lymphatic imaging (NIRF-LI) detection of dermal backflow, or retrograde lymphatic flow into initial lymphatics, was shown to precede clinical BCRL diagnosis by 8–23 months. Herein, we hypothesize that lymphatic pump failure is responsible for dermal backflow and may be a target to prevent onset of BCRL symptoms. Arm lymphatics in 51 patients with locally advanced breast cancer were visualized with NIRF-LI in a prospective, longitudinal, observational clinical cohort study. Lymphatic pumping frequencies were measured to investigate pumping changes during and after breast cancer treatment. Lymphatic pumping was quantified at five timepoints: after neoadjuvant chemotherapy, but before breast cancer excision and ALND, again at four weeks post-ALND, and at 6, 12, and 18 months post-RNI. Repeated measures mixed-effects analysis was used to compare the mean pumping frequencies amongst all time points. Additionally, pairwise comparisons between any two time points were performed using Wilcoxon matched-pairs signed rank test. As time lapsed after surgical treatment and RNI, ipsilateral dorsal forearm, ipsilateral ventral forearm, and ventral axilla pumping failure preceded the appearance of dermal backflow and clinically diagnosed BCRL, suggesting that lymphatic pumping dysfunction is the first step in BCRL development. This study suggests that impairment of the intrinsic lymph pump may be responsible for the onset of clinical BCRL symptoms, and therefore represents a target for prevention of cancer-acquired lymphedema. Future research is needed to understand the molecular determinants of the intrinsic lymphatic pump, and how cancer treatments and interventions can impact them.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aldrich et al. (2026) studied this question.

synapsesocial.com/papers/6996712d80e1323b05ec044ahttps://doi.org/10.1186/s13058-026-02231-w
Ask AI
Helpful
Bookmark
Share
View Full Paper